CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ 11,544	$ (3,731)
Adjustments to reconcile net income(loss) to net cash provided by operating activities:
Depreciation and amortization	3,606	1,537
Amortization of deferred financing costs	52	80
Amortization of debt fair value adjustment	(89)	0
Amortization of restricted stock and restricted stock units	974	538
Equity in earnings of unconsolidated joint ventures	(1,230)	1,345
Equity in earnings of sale of real estate of unconsolidated venture	(12,961)	0
Gain on sale of real estate	(6)	0
Increases and decreases from changes in other assets and liabilities:
(Increase) decrease in other assets	(1,071)	470
Decrease in accounts payable and accrued liabilities	(350)	(87)
Net cash provided by operating activities	469	152
Cash flows from investing activities:
Improvements to real estate properties	(802)	(223)
Purchase of investment in joint venture	(8,288)	0
Proceeds from the sale of real estate	4,385	0
Distributions from unconsolidated joint ventures	19,796	3,881
Contributions to unconsolidated joint ventures	(2,122)	0
Net cash provided by investing activities	12,969	3,658
Cash flows from financing activities:
Mortgage payoffs	(14,558)	0
Mortgage principal payments	(410)	(801)
Dividends paid	(4,198)	(3,777)
Proceeds from the sale of common stock	3,038	0
Net cash used in financing activities	(16,128)	(4,578)
Net decrease in cash, cash equivalents and restricted cash:	(2,690)	(768)
Cash, cash equivalents and restricted cash at beginning of period	38,921	28,685
Cash, cash equivalents and restricted cash at end of period	36,231	27,917
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	2,021	1,587
Cash paid for income taxes	1	6
Reclassification of property to held for sale	0	16,800
Consolidation on buyout of partnership interest:
Increase in real estate assets	(36,802)
Increase in other assets	(1,784)
Increase in mortgage payable	27,062
Increase in deferred loan costs	(364)
Increase on accounts payable and accrued liabilities	761
Decrease in investment in unconsolidated joint ventures	2,839
Purchase and consolidation of investment in joint venture	(8,288)	0
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.
Cash and cash equivalents	29,688	19,406
Restricted cash	6,543	8,511
Total cash, cash equivalents and restricted cash, shown in consolidated statement of cash flows	$ 36,231	$ 27,917